Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Molecular Genetics Laboratory London Health Sciences Centre Canada | 46 | 34 |
|
KIF1B - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 345 | 159 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Charcot-Marie-Tooth disease Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 50 | 43 |
|
Charcot-Marie-Tooth disease NGS panel HNL Genomics Connective Tissue Gene Tests United States | 50 | 43 |
|
Charcot-Marie-Tooth disease Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 50 | 43 |
|
Baylor Genetics United States | 842 | 637 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Hereditary Paraganglioma-Pheochromocytoma Genologica Medica Spain | 32 | 12 |
|
Charcot-Marie-Tooth disease: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 67 | 54 |
|
Charcot-Marie-Tooth Hereditary Neuropathy NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 76 | 54 |
|
Oxidative Phosphorylation Disorders NGS Panel Fulgent Genetics United States | 416 | 235 |
|
Charcot-Marie-Tooth Disease Type 2 , Panel Massive Sequencing (NGS) 20 Genes Reference Laboratory Genetics Spain | 24 | 20 |
|
Motor Neuron Disorder and Related Diseases , Panel Massive Sequencing (NGS) 49 Genes Reference Laboratory Genetics Spain | 60 | 49 |
|
Charcot-Marie-Tooth Disease, Panel Massive Sequencing (NGS) 32 Genes Reference Laboratory Genetics Spain | 41 | 32 |
|
CHARCOT-MARIE-TOOTH DISEASE TYPE 2A1 Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Charcot-Marie-Tooth Disease Type 2A1 , Sequencing KIF1B Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 329 | 127 |
|
Charcot-Marie-Tooth neuropathy type 2A1 Bioarray Spain | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.